Pages that link to "Q40651237"
Jump to navigation
Jump to search
The following pages link to Marc Auriacombe (Q40651237):
Displaying 50 items.
- Brigitte Aubert (Q462235) (← links)
- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings (Q24202319) (← links)
- Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings (Q24202323) (← links)
- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings (Q24245399) (← links)
- Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings (Q24245424) (← links)
- Selective serotonin re-uptake inhibitors and the risk of bleeding (Q28211440) (← links)
- Coefficient alpha and the internal structure of tests (Q29042519) (← links)
- DSM-5 criteria for substance use disorders: recommendations and rationale (Q30544314) (← links)
- Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. (Q33851850) (← links)
- Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study (Q33957119) (← links)
- Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria (Q34049049) (← links)
- Benzodiazepine withdrawal in subjects on opiate substitution treatment (Q34513898) (← links)
- Cannabis and psychosis: search of a causal link through a critical and systematic review (Q34611771) (← links)
- Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. (Q36908238) (← links)
- Why buprenorphine is so successful in treating opiate addiction in France (Q36960169) (← links)
- An overview of and rationale for changes proposed for pathological gambling in DSM-5 (Q37042976) (← links)
- A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study (Q37258183) (← links)
- Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002. (Q37405474) (← links)
- Relationship between anxiety disorders and opiate dependence--a systematic review of the literature: implications for diagnosis and treatment (Q37684275) (← links)
- Effectiveness of therapeutic communities: a systematic review (Q37945507) (← links)
- The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders (Q37997189) (← links)
- Ecological momentary assessment in the investigation of craving and substance use in daily life: a systematic review (Q38338253) (← links)
- Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. (Q38685426) (← links)
- Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions (Q39188761) (← links)
- Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of Pathological Gambling criteria (Q39702106) (← links)
- Borna disease virus RNA in immunocompromised patients in southwestern France (Q40404138) (← links)
- French field experience with buprenorphine (Q40502352) (← links)
- Association between morningness/eveningness, addiction severity and psychiatric disorders among individuals with addictions (Q40651080) (← links)
- A randomized double-blind study of neuroelectric therapy in opiate and cocaine detoxification (Q41131510) (← links)
- Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues (Q41420189) (← links)
- The DSM-5 field trials and reliability of alcohol use disorder (Q41865972) (← links)
- Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy (Q42619415) (← links)
- Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients (Q43838712) (← links)
- Social phobia and premature ejaculation: a case-control study (Q44274092) (← links)
- Sensation seeking as a common factor in opioid dependent subjects and high risk sport practicing subjects. A cross sectional study (Q44332660) (← links)
- Ecological momentary assessment in alcohol, tobacco, cannabis and opiate dependence: a comparison of feasibility and validity (Q44910543) (← links)
- Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence (Q45401403) (← links)
- Examining the influence of drop-outs in a follow-up of maintained opiate users (Q46651925) (← links)
- Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus (Q47569876) (← links)
- Griffiths et al.'s comments on the international consensus statement of internet gaming disorder: furthering consensus or hindering progress? (Q48088150) (← links)
- Cerebral blood flow modulation by transcutaneous cranial electrical stimulation with Limoge's current (Q48239121) (← links)
- Transcutaneous electrical stimulation with Limoge current potentiates morphine analgesia and attenuates opiate abstinence syndrome (Q48879335) (← links)
- Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances (Q50083669) (← links)
- Moving internet gaming disorder forward: A reply (Q50629066) (← links)
- Internet gaming and addiction: a reply to King & Delfabbro (Q50649117) (← links)
- An international consensus for assessing internet gaming disorder using the new DSM-5 approach (Q50664005) (← links)
- Use of midazolam for ECT anesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings (Q51612905) (← links)
- Transcranial electrical stimulation with high frequency intermittent current (Limoge's) potentiates opiate-induced analgesia: blind studies (Q51727673) (← links)
- Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals (Q51861543) (← links)
- Body dysmorphic disorder in a sample of cosmetic surgery applicants (Q51945206) (← links)